REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Sem Ilac San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Farm Supplies Merchant Wholesalers
Full name: Pharma Sem Ilac Sanayi Ve Ticaret Limited Sirketi Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Pharma Sem Ilac Sanayi Ve Ticaret Limited Sirketi is a Turkey-based company operating in the animal health and nutrition industry. They offer a wide range of products for ruminants, winged animals, pets, and fish, including dietary supplements, antibiotics, and insecticides. The company also provides solutions to reduce ammonia formation and emissions in intensive livestock. Pharma Sem Ilac Sanayi Ve Ticaret Limited Sirketi is focused on developing innovative products and solutions to improve animal health and nutrition.

Headquarters
N:19/a-b Talatpasa Caddesi Bahcelievler
Istanbul; Marmara; Postal Code: 34180

Contact Details: Purchase the Pharma Sem Ilac San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.pharmasem.com.tr

Basic Information
Total Employees:
Purchase the Pharma Sem Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Pharma Sem Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
June 11, 2007
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Pharma Sem Ilac San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
87.72%
Total operating revenue
87.72%
Operating profit (EBIT)
106.88%
Net Profit (Loss) for the Period
34.73%
Total assets
11.67%
Total equity
20.77%
Operating Profit Margin (ROS)
1.16%
Net Profit Margin
-1.93%
Return on Equity (ROE)
1.62%
Debt to Equity Ratio
1.41%
Quick Ratio
0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?